中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
28期
126-127
,共2页
急性脑梗死%纤溶酶%血塞通
急性腦梗死%纖溶酶%血塞通
급성뇌경사%섬용매%혈새통
Acute cerebral infarction%Plasminogen%Xuesaitong
目的 探讨以纤溶酶联合血塞通对急性脑梗死进行治疗所得到临床效果. 方法 整群选择2014年4月—2015年3月曾在该院接受治疗的急性脑梗死患者108例,以随机方式分为观察组与对照组,对照组中患者选择血塞通进行治疗,观察组中患者在对照组基础上联合纤溶酶进行治疗. 结果 对照组中患者临床有效率为74.1%,观察组中患者临床总有效率能够达到92.6%;观察组中患者治疗前后评分平均为(26.6±8.6)分、(8.4±2.4)分,对照组中患者治疗前后评分分别为平均(26.8± 8.8)分、(14.5±3.5)分;观察组患者治疗前后神经功能缺损程度评分与对照组相比明显较优秀;两组患者均无严重不良反应发生. 结论 以纤溶酶联合血塞通对急性脑梗死进行治疗能够得到较理想临床效果,可有效改善患者临床症状,增强患者神经功能,并且不会发生严重不良反应.
目的 探討以纖溶酶聯閤血塞通對急性腦梗死進行治療所得到臨床效果. 方法 整群選擇2014年4月—2015年3月曾在該院接受治療的急性腦梗死患者108例,以隨機方式分為觀察組與對照組,對照組中患者選擇血塞通進行治療,觀察組中患者在對照組基礎上聯閤纖溶酶進行治療. 結果 對照組中患者臨床有效率為74.1%,觀察組中患者臨床總有效率能夠達到92.6%;觀察組中患者治療前後評分平均為(26.6±8.6)分、(8.4±2.4)分,對照組中患者治療前後評分分彆為平均(26.8± 8.8)分、(14.5±3.5)分;觀察組患者治療前後神經功能缺損程度評分與對照組相比明顯較優秀;兩組患者均無嚴重不良反應髮生. 結論 以纖溶酶聯閤血塞通對急性腦梗死進行治療能夠得到較理想臨床效果,可有效改善患者臨床癥狀,增彊患者神經功能,併且不會髮生嚴重不良反應.
목적 탐토이섬용매연합혈새통대급성뇌경사진행치료소득도림상효과. 방법 정군선택2014년4월—2015년3월증재해원접수치료적급성뇌경사환자108례,이수궤방식분위관찰조여대조조,대조조중환자선택혈새통진행치료,관찰조중환자재대조조기출상연합섬용매진행치료. 결과 대조조중환자림상유효솔위74.1%,관찰조중환자림상총유효솔능구체도92.6%;관찰조중환자치료전후평분평균위(26.6±8.6)분、(8.4±2.4)분,대조조중환자치료전후평분분별위평균(26.8± 8.8)분、(14.5±3.5)분;관찰조환자치료전후신경공능결손정도평분여대조조상비명현교우수;량조환자균무엄중불량반응발생. 결론 이섬용매연합혈새통대급성뇌경사진행치료능구득도교이상림상효과,가유효개선환자림상증상,증강환자신경공능,병차불회발생엄중불량반응.
Objective To investigate the fibrinolytic enzyme joint plug with blood on treatment of acute cerebral infarction by clin-ical effect. Methods In April 2014 - March 2015 in our hospital for treatment of 108 patients with acute cerebral infarction were divided into observation group and control group in random way, in the control group patients choose blood plug for treatment, pa-tients in observation group based linked synthetic fiber dissolving enzyme treatment in the control group. Results The clinical ef-fective rate was 74.1%in control group and observation group of patients with clinical total effective rate can reach 92.6%;Obser-vation group patients before and after treatment in scoring with an average of (26.6±8.6) points, (8.6±2.4) points, control group pa-tients before and after treatment in the score, respectively, on average, (26.8±8.8), (14.5±3.5) mm; Observation group of patients before and after treatment degree of nerve function defect score compared with the control group obviously the better; Two groups of patients had no serious adverse reactions. Conclusion Fibrinolytic enzyme joint plug with blood on treatment of acute cerebral infarction can get ideal clinical effect, can effectively improve the patients' clinical symptoms, enhance the neural function in pa-tients with and without serious adverse reaction.